Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Dapagliflozin in Diabetes
IRCT20251108067913N2Phase 2Recruiting
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dapagliflozin in diabetes mellitus (DM), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Aug 2026; status: recruiting.
02
Drugs
dapagliflozin
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on IRCT20251108067913N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251108067913N2.